ET Intelligence Group: For those having a bullish view on the pharma sector in wake of the pandemic and not sure about which stocks might do well can consider investing in a pharma mutual funds rather than individual pharma stocks.
Data compiled by ET Intelligence Group show the top pharma MF schemes have outperformed the benchmark pharma indices like Nifty Pharma and BSE Healthcare Index as well as most individual pharma stocks.
Nippon India Pharma Fund, ICICI Prudential Pharma Healthcare & Diagnostics Fund, SBI Healthcare Opportunity Fund, Mirae Asset Healthcare Fund and DSP Healthcare Fund are the most popular pharma funds with the highest assets under management.
Pharma: Pharma sector mutual funds prove better bet than stocks, and how! indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
These 10 equity mutual funds gave over 50% return in 2020
The March crash saw people exit MFs but those who remained invested made good gains as the market staged a dramatic comeback. January 02, 2021 / 07:27 AM IST The year 2020 was a roller-coaster for mutual fund investors. When the coronavirus outbreak sent the market into a free fall earlier in the year, thousands of people either redeemed their investments or stopped their SIPs in panic. But those who kept their cool and stayed invested made some good gains, as markets staged a dramatic comeback to end the year on a high. Here is a list of 10 equity mutual schemes that gained more than 50 percent during the year. We only looked at schemes with assets under management valued at more than Rs 500 crore. (Data Source: ACE MF)